Oligometastatic Solid Cancer clinical trials

Explore recruiting oligometastatic solid cancer clinical trials.

Recruiting oligometastatic solid cancer studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Oligometastatic Solid Cancer trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Pan-lesions SBRT combined with lymphocyte support through ATRA-driven blockade of MDSC in patients with oligometastatic solid cancer (LySATRA)

France

Phase I and Phase II (Integrated)- Other EU CTIS Study details

Oligometastatic Solid Cancer trials by city

Oligometastatic Solid Cancer in Toronto Oligometastatic Solid Cancer in Vancouver Oligometastatic Solid Cancer in Montreal Oligometastatic Solid Cancer in Calgary Oligometastatic Solid Cancer in Edmonton Oligometastatic Solid Cancer in Ottawa Oligometastatic Solid Cancer in Winnipeg Oligometastatic Solid Cancer in Quebec City Oligometastatic Solid Cancer in Hamilton Oligometastatic Solid Cancer in Kitchener Oligometastatic Solid Cancer in London Oligometastatic Solid Cancer in Halifax Oligometastatic Solid Cancer in New York Oligometastatic Solid Cancer in Los Angeles Oligometastatic Solid Cancer in Chicago Oligometastatic Solid Cancer in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease